Cardiac resynchronization therapy in acute heart failure and left bundle-branch block in a real-life registry
Main Article Content
Objective:
To determine the prevalence, characteristics, timing of implementation and prognosis of patients with left bundle branch block (LBBB) and acute heart failure (AHF) treated with cardiac resynchronization therapy (CRT) in a real-life registry.
Methods:
We analysed the characteristics of patients with AHF and LBBB at the time of inclusion in the EAHFE (Epidemiology Acute Heart Failure Emergency) cohort to determine the indication for CRT, the timing of implementation and its impact on 10-year all-cause mortality.
Results:
729 patients with a median age of 82 years and there was a high burden of comorbidities and functional dependence. The median left-ventricle ejection fraction (LVEF) was 40%. Forty-six (6%) patients were treated with CRT at some point during follow-up, with a median time of delay for CRT implementation of 960 (IQR=1147 days) and at least 108 more untreated patients fulfilled criteria for CRT. Patients receiving CRT were younger, had different comorbidities, less functional dependence (higher Barthel index) and lower LVEF values. The median follow-up was 5.7 years (95% CI: 5.6-5.8) and CRT was not associated with changes in 10-year mortality (adjusted HR 1.33, 95% CI: 0.72-2.48; p-value 0.4). When compared with untreated patients fulfilling criteria for CRT, very similar results were observed (adjusted HR 1.34, 95% CI: 0.67-2.68).
Conclusions:
CRT implementation was delayed and underused in patients with AHF and LBBB. Under these circumstances, CRT is not associated with a reduction in all-cause mortality in the long term.
- Heart failure
- bundle-branch block
- cardiac resynchronization therapy
- Stroke Volume
- Pacemaker, Artificial
- Real world data
- McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., Cleland, J. G. F., Coats, A. J. S., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., Lainscak, M., … ESC Scientific Document Group (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 42(36), 3599–3726. https://doi.org/10.1093/eurheartj/ehab368 DOI: https://doi.org/10.1093/eurheartj/ehab368
- Cleland, J. G. F., Bristow, M. R., Freemantle, N., Olshansky, B., Gras, D., Saxon, L., Tavazzi, L., Boehmer, J., Ghio, S., Feldman, A. M., Daubert, J. C., & de Mets, D. (2022). The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HF. European journal of heart failure, 24(6), 1080–1090. https://doi.org/10.1002/ejhf.2524 DOI: https://doi.org/10.1002/ejhf.2524
- Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A. J. S., Deharo, J. C., Delgado, V., Diller, G. P., Israel, C. W., Keren, A., Knops, R. E., Kotecha, D., Leclercq, C., … Witte, K. K. (2022). 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(1), 71–164. https://doi.org/10.1093/europace/euab232 DOI: https://doi.org/10.1093/europace/euac023
- Raatikainen, M. J., Arnar, D. O., Zeppenfeld, K., Merino, J. L., Levya, F., Hindriks, G., & Kuck, K. H. (2015). Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 17 Suppl 1, i1–i75. https://doi.org/10.1093/europace/euu300 DOI: https://doi.org/10.1093/europace/euu300
- Mullens, W., Auricchio, A., Martens, P., Witte, K., Cowie, M. R., Delgado, V., Dickstein, K., Linde, C., Vernooy, K., Leyva, F., Bauersachs, J., Israel, C. W., Lund, L. H., Donal, E., Boriani, G., Jaarsma, T., Berruezo, A., Traykov, V., Yousef, Z., Kalarus, Z., … Leclercq, C. (2020). Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology. European journal of heart failure, 22(12), 2349–2369. https://doi.org/10.1002/ejhf.2046 DOI: https://doi.org/10.1002/ejhf.2046
- Llorens, P., Javaloyes, P., Martín-Sánchez, F. J., Jacob, J., Herrero-Puente, P., Gil, V., Garrido, J. M., Salvo, E., Fuentes, M., Alonso, H., Richard, F., Lucas, F. J., Bueno, H., Parissis, J., Müller, C. E., Miró, Ò., & ICA-SEMES Research Group (2018). Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clinical research in cardiology, 107(10), 897–913. https://doi.org/10.1007/s00392-018-1261-z DOI: https://doi.org/10.1007/s00392-018-1261-z
- Lévesque, L. E., Hanley, J. A., Kezouh, A., & Suissa, S. (2010). Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ (Clinical research ed.), 340, b5087. https://doi.org/10.1136/bmj.b5087 DOI: https://doi.org/10.1136/bmj.b5087
- Bradburn, M. J., Clark, T. G., Love, S. B., & Altman, D. G. (2003). Survival analysis part II: multivariate data analysis--an introduction to concepts and methods. British journal of cancer, 89(3), 431–436. https://doi.org/10.1038/sj.bjc.6601119 DOI: https://doi.org/10.1038/sj.bjc.6601119
- Osmanska, J., Hawkins, N. M., Toma, M., Ignaszewski, A., & Virani, S. A. (2018). Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC heart failure, 5(4), 668–674. https://doi.org/10.1002/ehf2.12297 DOI: https://doi.org/10.1002/ehf2.12297
- Aguiló, O., Castells, X., Miró, Ò., Mueller, C., Chioncel, O., & Trullàs, J. C. (2022). The prognostic significance of bundle branch block in acute heart failure: a systematic review and meta-analysis. Clinical research in cardiology: official journal of the German Cardiac Society, 10.1007/s00392-022-02105-z. Advance online publication. https://doi.org/10.1007/s00392-022-02105-z DOI: https://doi.org/10.1007/s00392-022-02105-z
Downloads
Accepted 2024-04-29
Published 2024-10-03

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
https://orcid.org/0000-0001-8695-8508